Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDV-Insulin Lispro vs Insulin Lispro in T1DM
NCT03096392Phase 2Completed
- Sponsor
- Diasome Pharmaceuticals
- Start
- Apr 2017
- Primary completion
- Nov 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of HDV-Insulin Lispro in type 1 diabetes mellitus (T1D), sponsored by Diasome Pharmaceuticals. Started Apr 2017; status: completed.
02
Drugs
HDV-Insulin Lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03096392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096392.